(Alliance News) - (Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News: Read More
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News: Read More
Instem PLC - Staffordshire, England-based provider of IT services to life sciences market - On Thursday, reports required majority of shareholders back the resolution to approve the scheme by which the takeover of Instem by Archimed SAS will be facilitated. Further, shareholders approve special resolution to amend company's articles. Plans to seek court sanction of the scheme on November 16, with the scheme becoming effective on November 20. Read More
Instem PLC - Staffordshire, England-based provider of IT services to life sciences market - Intends to adjourn the court meeting and the general meeting relating to the Archimed offer. These were scheduled to be held on October 19 and will now take place on November 2. Decision follows the disclosure by Instem today that since August 30, when the Archimed bid was announced, the firm has received approaches from five separate parties which could have led to a competing offer. However, states all parties have now withdrawn their interest. Believes shareholders should be allowed extra time to consider their votes, hence the delay. Stresses the Archimed offer will not lapse as a result of this announcement. Reaffirms view that the Archimed offer ascribes a highly attractive valuation. Read More
Instem PLC - Staffordshire, England-based provider of IT services to life sciences market - Takeover offer from funds managed by Archimed SAS is declared final and won't be increased. Back in August, Instem agreed to an offer from Archimed of 833 pence per share in cash. This values Instem at GBP203 million in total. Archimed is a specialist healthcare investor registered in Lyon, France, with offices also in New York and Singapore. The court and general meetings to approval the takeover are scheduled for Thursday next week. Read More
(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Friday. Read More
(Alliance News) - Instem PLC on Friday said it swung to a pretax loss in the six months ended June 30 on higher employee costs, but reported topline growth despite the "market weakness" during the period. Read More
(Alliance News) - The FTSE 100 was outperforming its European peers around midday on Wednesday, amid news that eurozone economic sentiment deteriorated in August. Read More
(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Wednesday. Read More
(Alliance News) - Stock prices in London opened higher on Wednesday, as market sentiment continued to be lifted by Tuesday's weak US data which is driving up hopes that interest rates have peaked. Read More
(Alliance News) - Instem PLC on Wednesday said it has agreed to a private equity takeover offer that values the life sciences IT company at just above GBP200 million. Read More
(Alliance News) - Instem PLC on Tuesday said it expects revenue to rise in the first half of 2023, driven by recurring software revenue growth. Read More
(Alliance News) - Instem PLC on Monday reported growth in profit and revenue last year, and said its in silico portfolio will be a significant area of planned investment as it seeks to take advantage of industry consolidation in 2023. Read More
(Alliance News) - Instem PLC on Thursday said it agreed a new five-year contract with the US government's National Toxicology Programme, further expanding its use of Instem's preclinical software and allowing access to new applications. Read More
(Alliance News) - The following is a round-up of updates on exposure to Silicon Valley Bank by London-listed companies, issued on Monday and not separately reported by Alliance News: Read More
(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News: Read More
Instem PLC - Staffordshire, England-based life science software - Extends contract with a "global contract research organisation", worth about USD1.4 million, for over 900 additional users of Instem's Provantis non-clinical study management platform. As a result, the CRO will now have about 7,400 Provantis users. "The significantly expanded number of users of the Provantis platform will help the client to meet demand for its non-clinical study services, which continue to grow across the pharmaceutical, biotech and agrochemical markets". Read More
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News: Read More